NASDAQ : ALEC
Alector, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 2.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 327.65M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 311.34M |
| Enterprise Value | 171.30M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 148.26M |
| Shares Outstanding | 148.26M |
| Shares Change (YoY) | +9.71% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 4.94% |
| Owned by Institutions (%) | 58.79% |
| Float | 101.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.63 |
| Forward PS | 3.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 13.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.26 |
| Quick Ratio | 5.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -385.11% |
| Return on Assets (ROA) | -27.62% |
| Return on Invested Capital (ROIC) | -73.28% |
| Return on Capital Employed (ROCE) | -73.28% |
| Weighted Average Cost of Capital (WACC) | 6.93% |
| Revenue Per Employee | $134,592 |
| Profits Per Employee | -$1.14M |
| Employee Count | 103 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 298,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +42.86% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 2.03 |
| Relative Strength Index (RSI) | 54.36 |
| Average Volume (20 Days) | 2,940,463 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10.25M |
| Short Previous Month | 6.15M |
| Short % of Shares Out | 6.92% |
| Short % of Float | 10.12% |
| Short Ratio (days to cover) | 1.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.86M |
| Gross Profit | -85.27M |
| Operating Income | -123.56M |
| Pretax Income | -117.56M |
| Net Income | -117.85M |
| EBITDA | -119.03M |
| EBIT | -123.56M |
| Loss Per Share | -$1.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 172.80M |
| Total Debt | 32.76M |
| Net Cash | 140.04M |
| Net Cash Per Share | $0.94 |
| Equity (Book Value) | -9.97M |
| Book Value Per Share | -0.09 |
| Working Capital | 145.85M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -158.23M |
| Capital Expenditures | -160,000 |
| Depreciation & Amortization | 4.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -158.39M |
| FCF Per Share | -$1.07 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | -891.32% |
| Pretax Margin | -847.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.71% |
| Shareholder Yield | -9.71% |
| Earnings Yield | -51.72% |
| FCF Yield | -48.34% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.90 |
| Price Target Difference | 85.71% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -24.66% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.49 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |